本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cellectar Biosciences Inc.

4.80
+0.07001.48%
盘后4.880.0800+1.67%16:56 EDT
成交量:23.90万
成交额:117.94万
市值:869.78万
市盈率:-0.21
高:5.17
开:5.17
低:4.61
收:4.73
数据加载中...
2024/04/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/01

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

重要事件披露

Form 8-K - Current report
2024/01/31

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

重要事件披露

Form 8-K - Current report
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/30

重要事件披露

Form 8-K - Current report
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/10/28

重要事件披露

Form 8-K - Current report
2023/10/27

SEC问询函

Form CORRESP - Correspondence